tim.hodson
Fri, 11/07/2025 – 15:11
Nov. 3, 2025 — RevealDx, a leader in the characterization of lung nodules, has introduced MDR Certification of RevealAI-Lung.
The RevealDX product, RevealAI-Lung, characterizes nodules by producing a score called the Malignancy Similarity Index (mSI) to assist radiologists with the creation of follow-up recommendations. The company has validated the software on more than 1,500 patients from a variety of cohorts. RevealAI-Lung is the first device …